1-1 of 1
Katarzyna Kapelko-Slowik, PhD
Close
Sort by
Journal Articles

Is CD94/NKG2A a Novel Target for Lymphoid Malignancies Immunotherapy?.

Donata Urbaniak-Kujda, PhD, Jaroslaw Dybko, MD, Iwona Prajs, MSci, Marek Kielbinski, PhD, Beata Tomaszewska-Toporska, MD, Katarzyna Kapelko-Slowik, PhD, Kazimierz Kuliczkowski, PhD
Journal: Blood
Blood (2006) 108 (11): 4650.
https://doi.org/10.1182/blood.V108.11.4650.4650
Published: 2006